Now ChromaDex has delivered to Spherix a plan to explore the expansion of D-tagatose into the sports nutrition and nutraceutical markets. D-tagatose is a natural sweetener present in only small amounts in fruits and dairy products. However, it can be produced commercially through an enzymatic process that starts with other natural sugars.
D-tagatose has the same bulk and sweetness of regular sugar (glucose). But it has a proven prebiotic effect and a low caloric value of only 1.5 kilocalorie per gram. It also has a glycemic and insulin index of only 3 percent of glucose. This makes D-tagatose an ideal solution as an ingredient for sweet and savory products since it provides the bonus of a health benefit.
That should make it possibly more valuable than other sweeteners in a range of products. ChromaDex had been granted an option previously by Spherix to commercialize D-tagatose based products.
Further information on D-tagatose can be found at either www.chromadex.com or www.spherix.com.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
